In last trading session, Pfizer Inc. (NYSE:PFE) saw 22.51 million shares changing hands with its beta currently measuring 0.68. Company’s recent per share price level of $28.88 trading at $0.19 or 0.66% at ring of the bell on the day assigns it a market valuation of $163.65B. That closing price of PFE’s stock is at a discount of -39.79% from its 52-week high price of $40.37 and is indicating a premium of 12.74% from its 52-week low price of $25.20. Taking a look at company’s average trading volume volume of 42.71 million if we extend that period to 3-months.
Pfizer Inc. (NYSE:PFE) trade information
Upright in the green during last session for gaining 0.66%, in the last five days PFE remained trading in the green while hitting it’s week-highest on Wednesday, 05/22/24 when the stock touched $28.88 price level, adding 2.53% to its value on the day. Pfizer Inc.’s shares saw a change of 0.31% in year-to-date performance and have moved 0.84% in past 5-day. Pfizer Inc. (NYSE:PFE) showed a performance of 14.33% in past 30-days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pfizer Inc. (PFE) estimates and forecasts
Statistics highlight that Pfizer Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -4.75% of value to its shares in past 6 months, showing an annual growth rate of 29.35% while that of industry is 5.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -4.30% from the last financial year’s standing.
14 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 12.05B for the same. And 13 analysts are in estimates of company making revenue of 13.67B in the next quarter. Company posted 12.73B and 13.23B of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -27.43% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 27.63% while estimates for its earnings growth in next 5 years are of -1.33%.
PFE Dividends
Pfizer Inc. is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
